Hutner Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.79M Sell
41,964
-1,132
-3% -$210K 3.54% 8
2025
Q1
$9.03M Buy
43,096
+693
+2% +$145K 3.85% 8
2024
Q4
$7.54M Buy
42,403
+3,901
+10% +$693K 3.64% 9
2024
Q3
$7.6M Sell
38,502
-63
-0.2% -$12.4K 3.78% 9
2024
Q2
$6.61M Sell
38,565
-500
-1% -$85.8K 3.63% 9
2024
Q1
$7.11M Buy
39,065
+7
+0% +$1.28K 3.86% 8
2023
Q4
$6.05M Sell
39,058
-832
-2% -$129K 3.57% 10
2023
Q3
$5.95M Sell
39,890
-394
-1% -$58.7K 3.65% 10
2023
Q2
$5.43M Buy
40,284
+17
+0% +$2.29K 3.17% 10
2023
Q1
$6.42M Buy
40,267
+85
+0.2% +$13.5K 3.91% 10
2022
Q4
$6.49M Buy
40,182
+433
+1% +$70K 4.02% 10
2022
Q3
$5.34M Buy
39,749
+91
+0.2% +$12.2K 3.73% 10
2022
Q2
$6.07M Sell
39,658
-81
-0.2% -$12.4K 3.99% 10
2022
Q1
$6.44M Sell
39,739
-158
-0.4% -$25.6K 3.68% 10
2021
Q4
$5.4M Sell
39,897
-395
-1% -$53.5K 3.15% 12
2021
Q3
$4.35M Buy
40,292
+186
+0.5% +$20.1K 2.84% 13
2021
Q2
$4.52M Sell
40,106
-677
-2% -$76.3K 2.89% 13
2021
Q1
$4.41M Buy
40,783
+2,383
+6% +$258K 2.89% 13
2020
Q4
$4.12M Buy
38,400
+86
+0.2% +$9.22K 2.87% 13
2020
Q3
$3.36M Buy
38,314
+4,265
+13% +$374K 2.49% 15
2020
Q2
$3.34M Buy
34,049
+9,256
+37% +$909K 2.83% 13
2020
Q1
$1.89M Sell
24,793
-50
-0.2% -$3.81K 1.73% 20
2019
Q4
$2.2M Sell
24,843
-210
-0.8% -$18.6K 1.52% 24
2019
Q3
$1.9M Hold
25,053
1.34% 24
2019
Q2
$1.82M Hold
25,053
1.3% 24
2019
Q1
$2.02M Sell
25,053
-942
-4% -$75.9K 1.48% 24
2018
Q4
$2.4M Buy
25,995
+730
+3% +$67.3K 1.87% 21
2018
Q3
$2.39M Hold
25,265
1.73% 22
2018
Q2
$2.34M Sell
25,265
-520
-2% -$48.2K 1.83% 21
2018
Q1
$2.44M Sell
25,785
-50
-0.2% -$4.73K 1.9% 19
2017
Q4
$2.5M Hold
25,835
1.78% 20
2017
Q3
$2.3M Hold
25,835
1.74% 20
2017
Q2
$1.87M Sell
25,835
-485
-2% -$35.2K 1.44% 22
2017
Q1
$1.72M Sell
26,320
-672
-2% -$43.8K 1.35% 23
2016
Q4
$1.69M Sell
26,992
-1,350
-5% -$84.5K 1.4% 23
2016
Q3
$1.79M Buy
+28,342
New +$1.79M 1.52% 24